Coronary heart disease (CHD), also called coronary artery disease (CAD), ischaemic heart disease, atherosclerotic
heart disease, is the end result of the accumulation of atheromatous plaques within the walls of the arteries that supply
the myocardium (the muscle of the heart) with oxygen and
nutrients. While the symptoms and signs of coronary heart disease are noted in the advanced state of disease, most individuals
with coronary heart disease show no evidence of disease for decades as the disease progresses before the first onset of symptoms,
often a "sudden" heart attack, finally arise. After decades of progression, some
of these atheromatous plaques may rupture and (along with the activation of the
blood clotting system) start limiting blood flow to the
heart muscle. The disease is the most common cause of sudden death[1], and is also the
most common reason for death of men and women over 20 years of age.[citation needed] According to present trends in the United States, half of healthy
40-year-old males will develop CHD in the future, and one in three healthy 40-year-old women.[2] According to the Guinness Book of
Records, Northern Ireland is the country with the most occurrences of CHD.
Overview
Atherosclerotic heart disease can be thought of as a wide spectrum of disease of the heart.
At one end of the spectrum is the asymptomatic individual with atheromatous streaks within
the walls of the coronary arteries (the arteries of the heart). These streaks represent the early stage of atherosclerotic heart
disease and do not obstruct the flow of blood. A coronary angiogram performed
during this stage of disease may not show any evidence of coronary artery disease, because the lumen of the coronary artery has
not decreased in calibre.
Over a period of many years, these streaks increase in thickness. While the atheromatous plaques initially expand into the
walls of the arteries, eventually they will expand into the lumen of the vessel, affecting the flow of blood through the
arteries. While it was originally believed that the growth of atheromatous plaques was a slow, gradual process, recent evidence
suggests that the gradual buildup may be complemented by small plaque ruptures which cause the sudden increase in the plaque
burden due to accumulation of thrombus material.
Intravascular ultrasound image of a coronary artery (left), with color coding
on the right, delineating the lumen (yellow), external elastic membrane (blue) and the atherosclerotic plaque burden (green). As
the plaque burden increases, the lumen size will decrease.
Atheromatous plaques that cause obstruction of less than 70 percent of the diameter of the vessel rarely cause symptoms of
obstructive coronary artery disease. As the plaques grow in thickness and obstruct more than 70 percent of the diameter of the
vessel, the individual develops symptoms of obstructive coronary artery disease. At this stage of the disease process, the
patient can be said to have ischemic heart disease. The symptoms of ischemic
heart disease are often first noted during times of increased workload of the heart. For instance, the first symptoms include
exertional angina or decreased exercise tolerance.
As the degree of coronary artery disease progresses, there may be near-complete obstruction of the lumen of the coronary artery, severely restricting the flow of oxygen-carrying blood to the myocardium.
Individuals with this degree of coronary heart disease typically have suffered from one or more myocardial infarctions (heart attacks), and may have signs and symptoms of chronic coronary
ischemia, including symptoms of angina at rest and flash pulmonary edema.
A distinction should be made between myocardial ischemia and myocardial infarction. Ischemia means that the amount of oxygen
supplied to the tissue is inadequate to supply the needs of the tissue. When the myocardium becomes ischemic, it does not
function optimally. When large areas of the myocardium becomes ischemic, there can be impairment in the relaxation and
contraction of the myocardium. If the blood flow to the tissue is improved, myocardial ischemia can be reversed. Infarction means
that the tissue has undergone irreversible death due to lack of sufficient oxygen-rich blood.
An individual may develop a rupture of an atheromatous plaque at any stage of the spectrum of coronary heart disease.
The acute rupture of a plaque may lead to an acute myocardial infarction (heart
attack).
Pathophysiology
Limitation of blood flow to the heart causes ischemia (cell starvation secondary to a lack
of oxygen) of the myocardial cells. When myocardial cells die from lack of oxygen, this is called
a myocardial infarction (commonly called a heart attack). It leads to
heart muscle damage, heart muscle death and later
scarring without heart muscle regrowth.
Myocardial infarction usually results from the sudden occlusion of a coronary artery when a plaque ruptures, activating the
clotting system and atheroma-clot interaction fills the lumen of the artery to the point of
sudden closure. The typical narrowing of the lumen of the heart artery before sudden closure is typically 20%, according to clinical research completed in
the late 1990s and using IVUS examinations within 6 months prior to a
heart attack. High grade stenoses as such
exceeding 75% blockage, such as detected by stress testing, were found to be
responsible for only 14% of acute heart attacks the rest being due to plaque
rupture/ spasm. The events leading up to plaque rupture are only partially understood. Myocardial infarction is also caused, far less commonly, by spasm of the artery wall occluding the
lumen, a condition also associated with atheromatous plaque and CHD.
CHD is associated with smoking, obesity,
hypertension and a chronic sub-clinical lack of vitamin C. A family history of CHD is one
of the strongest predictors of CHD. Screening for CHD includes evaluating homocysteine
levels, high-density and low-density
lipoprotein (cholesterol) levels and triglyceride levels.
Angina
Angina that occurs regularly with activity, upon awakening, or at other predictable
times is termed stable angina and is associated with high grade narrowings of the
heart arteries. The symptoms of angina are often treated with
nitrate preparations such as nitroglycerin, which come in
short-acting and long-acting forms, and may be administered transdermally, sublingually or orally. Many other more effective
treatments, especially of the underlying atheromatous disease, have been developed.
Angina that changes in intensity, character or frequency is termed unstable. Unstable angina may precede myocardial
infarction, and requires urgent medical attention. It is treated with morphine, oxygen, intravenous nitroglycerin, and aspirin.
Interventional procedures such as angioplasty may be done.
Risk factors
The following are confirmed independent risk factors for the development of CAD, in order
of decreasing importance:
- Hypercholesterolemia (specifically, serum LDL concentrations)
- Smoking
- Hypertension (high systolic pressure seems to be most significant in this regard)
- Hyperglycemia (due to diabetes mellitus or otherwise)
- Type A Behavioural Patterns, TABP. Added in 1981 as an independent risk factor
after a majority of research into the field discovered that TABP's were twice as likely to cause CHD than any other personality
type.
- Hereditary differences in such diverse aspects as lipoprotein structure and that of their associated receptors, homocysteine
processing/metabolism, etc.
Significant, but indirect risk factors include:
Prevention
Coronary heart disease is the most common form of heart disease in the Western world. Prevention centers on the modifiable
risk factors, which include decreasing cholesterol levels, addressing obesity and hypertension, avoiding a sedentary lifestyle, making healthy dietary choices, and stopping smoking. There is some evidence that lowering uric acid
and homocysteine levels may contribute. In diabetes
mellitus, there is little evidence that blood sugar control actually improves cardiac
risk. Some recommend a diet rich in omega-3 fatty acids and vitamin C. The World Health
Organization (WHO) recommends "low to moderate alcohol intake" to reduce risk of coronary heart disease.[3]
An increasingly growing number of other physiological markers and homeostatic mechanisms are currently under scientific investigation. Among these markers are
low density lipoprotein and asymmetric dimethylarginine. Patients with CHD and those trying to prevent CHD are advised
to avoid fats that are readily oxidized (e.g., saturated fats and trans-fats), limit
carbohydrates and processed sugars to reduce production of Low density
lipoproteins while increasing High density lipoproteins, keeping
blood pressure normal, exercise and stop smoking. These measures limit the progression of
the disease. Recent studies have shown that dramatic reduction in LDL levels can cause mild regression of coronary heart
disease.
Exercise
Separate to the question of the benefits of exercise; it is unclear whether doctors should spend time counseling patients to
exercise. The U.S. Preventive Services
Task Force (USPSTF), based on a systematic review of randomized controlled trials, found 'insufficient evidence' to recommend that doctors
counsel patients on exercise.[4]
However, the American Heart Association, based on a non-systematic review,
recommends that doctors counsel patients on exercise [5]
Preventive diets
-
It has been suggested that coronary heart disease is partially reversible using an intense dietary regimen coupled with
regular cardio exercise.[6]
- Vegetarian diet: Vegetarians have been shown to have a 24% reduced risk of dying of
heart disease.[7]
- Cretan Mediterranean diet: The Seven Country Study found that Cretan men had exceptionally low death rates from heart disease, despite moderate to high intake of fat. The
Cretan diet is similar to other traditional Mediterranean diets: consisting mostly of olive
oil, bread, abundant fruit and vegetables, a moderate amount of wine and fat-rich animal products such as lamb, sausage
and goat cheese.[8][9][10] However, the Cretan
diet consisted of less fish and wine consumption than some other Mediterranean-style diets, such as the diet in Corfu, another region of Greece, which had higher death rates.[citation needed]
The consumption of trans fat (commonly found in hydrogenated products such as margarine) has been shown to cause the
development of endothelial dysfunction, a precursor to atherosclerosis.[11]
Aspirin
Aspirin, in doses of less than 75 to 81 mg/d[12], can reduce the incidence of cardiovascular events.[13] The U.S. Preventive Services Task Force 'strongly recommends that clinicians discuss aspirin
chemoprevention with adults who are at increased risk for coronary heart disease'.[14] The Task Force defines increased risk as 'Men older than 40 years of
age, postmenopausal women, and younger persons with risk factors for coronary heart disease (for example, hypertension, diabetes,
or smoking) are at increased risk for heart disease and may wish to consider aspirin therapy'. More specifically, high-risk
persons are 'those with a 5-year risk ≥ 3%'. A risk calculator is available.[15]
Regarding healthy women, the more recent Women's Health Study randomized controlled trial found insignficant benefit from aspirin in the reduction of cardiac events; however there was a
signficant reduction in stroke.[16] Subgroup analysis showed that all benefit was confined to women over 65 years old.[16] In spite of the insignficant benefit for women < 65 years old, recent practice guidelines by the American Heart
Association recommend to 'consider' aspirin in 'healthy women' <65 years of age 'when benefit for ischemic stroke
prevention is likely to outweigh adverse effects of therapy'.[17]
Omega-3 fatty acids
The benefit of fish oil is controversial with conflicting conclusions reached by a negative meta-analysis[18] of randomized controlled trials by
the international Cochrane Collaboration and a partially positive
systematic review[19] by the Agency for Healthcare
Research and Quality. Since these two reviews, a randomized controlled
trial reported a reduction on coronary events in Japanese hypercholesterolemic patients.[20]
Omega-3 fatty acids are also found in some plant sources including
flax seed oil, hemp seed oil, and walnuts. Plant sources may be safer as fish products have been shown to contain heavy metals and other fat
soluble pollutants.
Secondary prevention
Secondary prevention is preventing further sequelae of already established disease. Regarding coronary heart disease, this can
mean risk factor management that is carried out during cardiac rehabilitation, a 4-phase process beginning in hospital after MI,
angioplasty or heart surgery and continuing for a minimum of three months. Exercise is a main component of cardiac rehabilitation
along with diet, smoking cessation, and blood pressure and cholesterol management.
Anti-platelet therapy
A meta-analysis of randomized controlled
trials by the international Cochrane Collaboration found "that the use of
clopidogrel plus aspirin is associated with a reduction in the risk of cardiovascular events compared with aspirin alone in
patients with acute non-ST coronary syndrome. In patients at high risk of cardiovascular disease but not presenting acutely,
there is only weak evidence of benefit and hazards of treatment almost match any benefit obtained.".[21]
Recent research
- Further information: atheroma and atherosclerosis
A 2006 study by the Cleveland Clinic found a region on Chromosome 17 was confined to
families with multiple cases of myocardial infarction.[22]
A more controversial link is that between Chlamydophila pneumoniae
infection and atherosclerosis.[23]
While this intracellular organism has been demonstrated in atherosclerotic plaques, evidence is inconclusive as to whether it can
be considered a causative factor.[citation needed] Treatment with antibiotics in patients with proven atherosclerosis has not
demonstrated a decreased risk of heart attacks or other coronary vascular diseases.[24]
References
- ^ http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1835183
- ^ http://circ.ahajournals.org/cgi/content/full/115/5/e69/TBL3179728
- ^ http://www.who.int/nutrition/topics/5_population_nutrient/en/index12.html
- ^ (2002) "Behavioral
counseling in primary care to promote physical activity: recommendation and rationale". Ann. Intern. Med. 137 (3):
205-7. PMID 12160370.
- ^ Thompson PD,
Buchner D, Pina IL, et al (2003). "Exercise and physical activity in the prevention and treatment of atherosclerotic
cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and
Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)".
Circulation 107 (24): 3109-16. DOI:10.1161/01.CIR.0000075572.40158.77. PMID 12821592.
http://www.ngc.gov/summary/summary.aspx?ss=15&doc_id=5360&string=#s23
- ^ Ornish D, Brown SE,
Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. (1990). "Can lifestyle changes
reverse coronary heart disease? The Lifestyle Heart Trial.". Lancet 336 (8708): 129-33. PMID
1973470.
- ^ Key TJ, Fraser GE,
Thorogood M, Appleby PN, Beral V, Reeves G, Burr ML, Chang-Claude J, Frentzel-Beyme R, Kuzma JW, Mann J, McPherson K (1998).
"Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five
prospective studies.". Public Health Nutr 1 (1): 33-41. PMID 10555529.
- ^ Willett WC, Sacks
F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D. (1995). "Mediterranean diet pyramid: a cultural model
for healthy eating.". Am J Clin Nutr 61 (6 Suppl): 1402S-1406S. PMID 7754995.
- ^ Perez-Llamas, F., et.al., J Hum Nutr Diet, Dec 1996, 9:6:463-471
- ^ Alberti-Fidanza A, Paolacci CA, Chiuchiu MP, Coli R, Fruttini D, Verducci G, Fidanza F. (1994). "Dietary
studies on two rural Italian population groups of the Seven Countries Study. 1. Food and nutrient intake at the thirty-first year
follow-up in 1991.". Eur J Clin Nutr 48 (2): 85-91. PMID 8194497.
- ^ Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. (2005).
"Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.". J Nutr
135 (3): 562-6. PMID 15735094.
- ^ Campbell CL, Smyth
S, Montalescot G, Steinhubl SR (2007). "Aspirin dose for the prevention of cardiovascular disease: a systematic review".
JAMA 297 (18): 2018-24. DOI:10.1001/jama.297.18.2018. PMID
17488967.
- ^ Berger J,
Roncaglioni M, Avanzini F, Pangrazzi I, Tognoni G, Brown D (2006). "Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific
meta-analysis of randomized controlled trials". JAMA 295 (3): 306-13. PMID 16418466.
- ^ (2002) "Aspirin for the primary prevention of
cardiovascular events: recommendation and rationale". Ann Intern Med 136 (2): 157-60. PMID
11790071.
- ^ http://www.med-decisions.com/
- ^ a b Ridker P, Cook N, Lee I, Gordon D,
Gaziano J, Manson J, Hennekens C, Buring J (2005). "A randomized trial of low-dose aspirin in the primary prevention of
cardiovascular disease in women". N Engl J Med 352 (13): 1293-304. DOI:10.1056/NEJMoa050613. PMID 15753114.
- ^ http://circ.ahajournals.org/cgi/content/abstract/CIRCULATIONAHA.107.181546v1
- ^ Hooper L, Thompson
RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB,
Davey Smith G (2006). "Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review".
BMJ 332 (7544): 752-60. DOI:10.1136/bmj.38755.366331.2F. PMID
16565093.
- ^ Wang C, Harris WS,
Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J (2006). "n-3 Fatty acids from fish or fish-oil supplements, but
not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic
review". Am. J. Clin. Nutr. 84 (1): 5-17. PMID 16825676.
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1a.chapter.38290
- ^ Yokoyama M, Origasa
H, Matsuzaki M, et al (2007). "Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients
(JELIS): a randomised open-label, blinded endpoint analysis". Lancet 369 (9567): 1090-8. DOI:10.1016/S0140-6736(07)60527-3. PMID 17398308.
- ^ Keller T, Squizzato
A, Middeldorp S (2007). "Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease". Cochrane
database of systematic reviews (Online) (3): CD005158. DOI:10.1002/14651858.CD005158.pub2. PMID
17636787.
- ^ Farrall M, Green
FR, Peden JF, Olsson PG, Clarke R, Hellenius ML, Rust S, Lagercrantz J, Franzosi MG, Schulte H, Carey A, Olsson G, Assmann G,
Tognoni G, Collins R, Hamsten A, Watkins H, on behalf of the PROCARDIS Consortium (2006). "Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome
17". PLoS Genetics 2 (5): e72. PMID 16710446.
- ^ Saikku P, Leinonen M,
Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. (1992). "Chronic Chlamydia pneumoniae
infection as a risk factor for coronary heart disease in the Helsinki Heart Study.". Ann Intern Med 116 (4): 273-8.
PMID 1733381.
- ^ Andraws R, Berger
JS, Brown DL. (2005). "Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of
randomized controlled trials.". JAMA 293 (21): 2641-7. PMID 15928286.
See also
External links
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)